000 01454 a2200409 4500
005 20250512050856.0
264 0 _c19880628
008 198806s 0 0 eng d
022 _a0009-7322
024 7 _a10.1161/01.cir.77.6.1291
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFananapazir, L
245 0 0 _aProcainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden death.
_h[electronic resource]
260 _bCirculation
_cJun 1988
300 _a1291-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAtrial Fibrillation
_xphysiopathology
650 0 4 _aCardiac Pacing, Artificial
650 0 4 _aDeath, Sudden
650 0 4 _aElectrocardiography
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aHeart Conduction System
_xdrug effects
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aProcainamide
650 0 4 _aRefractory Period, Electrophysiological
_xdrug effects
650 0 4 _aRisk Factors
650 0 4 _aWolff-Parkinson-White Syndrome
_xdiagnosis
700 1 _aPacker, D L
700 1 _aGerman, L D
700 1 _aGreer, G S
700 1 _aGallagher, J J
700 1 _aPressley, J C
700 1 _aPrystowsky, E N
773 0 _tCirculation
_gvol. 77
_gno. 6
_gp. 1291-6
856 4 0 _uhttps://doi.org/10.1161/01.cir.77.6.1291
_zAvailable from publisher's website
999 _c3376504
_d3376504